Everolimus Related Compound 2

Everolimus Related Compound 2 Structure
CAS No.
1062122-63-7
Chemical Name:
Everolimus Related Compound 2
Synonyms
Everolimus Impurity 4(804-95);Everolimus Related Compound 2;Everolimus EP Impurity B (804-95);EVEROLIMUS EP IMPURITY B/ EVEROLIMUS-19-ENE OPEN RING;Everolimus Impurity 4 (Everolimus EP Impurity B) (804-95);(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin Discontinued. please offer H825290;2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]ace...;2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-, (2S)-;(S)-1-(2-((2R,3R,6S)-2-Hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid (Everolimus Impurity)
CBNumber:
CB23380181
Molecular Formula:
C53H83NO14
Molecular Weight:
958.22
MOL File:
1062122-63-7.mol
Modify Date:
2023/5/9 9:30:36

Everolimus Related Compound 2 Properties

Boiling point 987.2±75.0 °C(Predicted)
Density 1.17±0.1 g/cm3(Predicted)
solubility Dichloromethane, Methanol
form Solid
pka 3.24±0.20(Predicted)
color Yellow

Everolimus Related Compound 2 Chemical Properties,Uses,Production

Uses

(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin is a metabolite of the immunosuppressant macrolide SDZ RAD (also known as Everolimus E945400) which is an analog of the parent drug Rapamycin (R124000).

Everolimus Related Compound 2 Preparation Products And Raw materials

Raw materials

Preparation Products

Everolimus Related Compound 2 Suppliers

Global( 33)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Allmpus Laboratories Pvt Ltd +91-9518738415 +91-9167862134 Maharashtra, India 657 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6257 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6739 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6514 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6754 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11922 58 Inquiry
QUALITY CONTROL SOLUTIONS LTD. 0755-66853366; 13670046396 China 24342 58 Inquiry
Nantong Hanfang Biotechnology Co. , Ltd. hanfangpharma@126.com; 18616537568 China 29981 58 Inquiry
Chengdu Peter-like Biotechnology Co., Ltd. 028-81700200 13308200041 China 11183 58 Inquiry
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4613 55 Inquiry
2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]ace... (19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin Discontinued. please offer H825290 Everolimus Impurity 4(804-95) Everolimus EP Impurity B (804-95) (S)-1-(2-((2R,3R,6S)-2-Hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid (Everolimus Impurity) Everolimus Impurity 4 (Everolimus EP Impurity B) (804-95) Everolimus Related Compound 2 EVEROLIMUS EP IMPURITY B/ EVEROLIMUS-19-ENE OPEN RING 2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-, (2S)- 1062122-63-7